비교리스트

 카트 문의
시장보고서
상품코드
1564107

세계의 생검 기기 시장

Biopsy Devices
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생검 기기 세계 시장은 2030년까지 59억 달러에 달할 것으로 예상

2023년에 43억 달러로 추정되는 생검 기기 세계 시장은 2023-2030년간 연평균 4.5%로 성장하여 2030년에는 59억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 초음파 유도하 생검은 CAGR 5.4%를 기록하여 분석 기간이 끝날 때까지 24억 달러에 도달할 것으로 예상되며, CT Scan-Guided Biopsy 분야의 성장률은 분석 기간 동안 CAGR 4.8%로 추정됩니다.

미국 시장은 12억 달러로 추정, 중국은 CAGR 4.2%로 성장 전망

미국 생검 기기 시장은 2023년 12억 달러 규모로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 4.2%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 9억 2,470만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 4.5%와 3.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.7%의 성장률을 보일 것으로 예상됩니다.

세계 생검장비 시장 - 주요 동향 및 촉진요인 요약

생검 기기가 주목받는 이유는?

생검 기기는 진단 과정, 특히 다양한 암의 조기 발견 및 모니터링의 핵심입니다. 최근 생검 기기의 기술 발전으로 정확성, 안전성 및 환자 편의성이 크게 향상되었습니다. 전통적인 바늘 생검부터 첨단 영상 유도 및 로봇 보조 방법까지, 이러한 장비의 진화는 눈부신 발전을 거듭하고 있습니다. 이러한 혁신은 조직 채취의 정확성을 향상시켰을 뿐만 아니라, 시술의 침습성을 최소화하여 회복 시간을 단축하고 합병증을 감소시키는 데 기여하고 있습니다. 초음파, MRI, CT 스캔과 같은 영상 기술과 생검 기기의 통합은 이 분야에 또 다른 혁명을 일으켜 시술 중 실시간 안내를 가능하게 하고, 채취된 샘플이 가장 관련성이 높은 부위에서 채취되도록 하여 진단 정확도를 높이고 있습니다.

최종 사용자 동향은 생검 기기 시장을 어떻게 형성하고 있는가?

생검 기기의 사용은 헬스케어 분야의 최종 용도 변화로 인해 눈에 띄게 변화하고 있습니다. 암 및 기타 만성 질환의 발병률이 증가함에 따라 조기 및 정확한 진단 도구에 대한 수요가 증가하고 있습니다. 병원과 진단센터가 생검 기기의 주요 사용자이지만, 외래 진료소와 암 전문센터가 이러한 기술을 채택하는 경향이 증가하고 있습니다. 이러한 변화는 정확하고 시기적절한 진단을 필요로 하는 조기 발견과 개인 맞춤형 의료에 대한 강조가 주요 원인으로 작용하고 있습니다. 또한, 전 세계 인구의 고령화와 정기적인 건강검진에 대한 인식이 높아지면서 일상적인 생검에 대한 수요가 증가하고 있습니다. 이러한 추세는 의료 인프라가 첨단 진단법을 뒷받침하는 선진국에서 특히 두드러지지만, 신흥국 시장도 빠르게 따라잡고 있어 이러한 장비에 대한 수요를 더욱 촉진하고 있습니다.

생검 기기의 미래를 바꿀 혁신은 무엇일까?

생검 기기의 미래는 환자 예후와 진단 정확도를 향상시키기 위한 끊임없는 혁신에 의해 형성되고 있습니다. 가장 중요한 발전 중 하나는 기존의 조직 생검을 대체할 수 있는 덜 침습적인 액체 생검의 등장입니다. 액체 생검은 혈액 샘플에서 순환하는 종양 세포와 DNA를 분석하여 수술 없이도 암의 존재와 진행에 대한 중요한 정보를 제공합니다. 또 다른 혁신 분야는 이차 오염과 감염의 위험을 줄이는 일회용 생검 기기의 개발입니다. 이러한 장비는 무균이 최우선시되는 환경에서 특히 가치가 있습니다. 또한, 로봇 보조 생검 기술의 발전은 시료 채취의 정확성과 일관성을 높이고, 인적 오류를 줄이며, 더 복잡한 시술을 더 쉽게 수행할 수 있게 해줍니다. 이러한 기술 혁신은 생검 과정의 효율성을 향상시킬 뿐만 아니라 생검으로 진단할 수 있는 질병의 범위를 확장하고 있습니다.

생검 기기 시장의 성장 원동력은?

생검 기기 시장의 성장은 여러 가지 요인에 의해 주도되고 있습니다. 암 및 기타 만성 질환의 유병률 증가로 인해 조기 및 정확한 진단에 대한 필요성이 대두되고 있으며, 이는 시장 성장의 주요 동인 중 하나입니다. 영상기술의 통합과 저침습적 생검 기술의 개발 등 기술 발전으로 생검의 정확성과 안전성이 크게 향상되어 환자들에게 보다 친숙하고 수용 가능한 검사로 거듭나고 있습니다. 또한, 개인 맞춤형 의료의 발전으로 인해 개인의 질병 특성에 맞는 치료가 점점 더 많이 이루어지고 있으며, 이는 정밀 진단 도구에 대한 수요를 촉진하고 있습니다. 또한, 신흥 시장의 의료 인프라가 확대되면서 첨단 생검 기기 도입에 대한 새로운 기회가 창출되고 있습니다. 암 연구 및 조기 진단 프로그램에 대한 정부의 지원과 재정적 지원도 시장 성장에 중요한 역할을 하고 있습니다. 조기 발견의 중요성에 대한 인식이 높아짐에 따라 생검 기기 시장은 기술 혁신과 세계 의료 관행의 변화로 인해 지속적인 수요가 발생할 것으로 예상됩니다.

조사 대상 기업 예시(총 46건)

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.10.04

Global Biopsy Devices Market to Reach US$5.9 Billion by 2030

The global market for Biopsy Devices estimated at US$4.3 Billion in the year 2023, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Ultrasound-Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the CT Scan-Guided Biopsy segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 4.2% CAGR

The Biopsy Devices market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$924.7 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Biopsy Devices Market - Key Trends and Drivers Summarized

Why Are Biopsy Devices Gaining Attention?

Biopsy devices have become a cornerstone in the diagnostic process, particularly in the early detection and monitoring of various cancers. Recent technological advancements in biopsy devices have significantly improved their accuracy, safety, and patient comfort. From traditional needle biopsies to advanced image-guided and robotic-assisted techniques, the evolution of these devices is remarkable. These innovations have not only enhanced the precision of tissue sampling but also minimized the invasiveness of the procedure, leading to quicker recovery times and fewer complications. The integration of imaging technologies like ultrasound, MRI, and CT scans with biopsy devices has further revolutionized the field, enabling real-time guidance during the procedure and ensuring that the samples collected are from the most relevant areas, thereby increasing diagnostic accuracy.

How Are End-Use Trends Shaping the Biopsy Devices Market?

The utilization of biopsy devices is seeing a notable shift, driven by changes in end-use trends within the healthcare sector. With the rising incidence of cancer and other chronic diseases, there is an increasing demand for early and accurate diagnostic tools. Hospitals and diagnostic centers are the primary users of biopsy devices, but there’s a growing trend of outpatient clinics and specialized cancer centers adopting these technologies. This shift is largely due to the emphasis on early detection and personalized medicine, which requires precise and timely diagnosis. Moreover, the aging global population, coupled with the growing awareness of regular health check-ups, is driving the demand for routine biopsy procedures. This trend is particularly noticeable in developed regions, where healthcare infrastructure supports advanced diagnostic practices, but emerging markets are quickly catching up, further fueling the demand for these devices.

What Innovations Are Shaping the Future of Biopsy Devices?

The future of biopsy devices is being shaped by continuous innovations aimed at improving patient outcomes and diagnostic accuracy. One of the most significant developments is the advent of liquid biopsies, which offer a less invasive alternative to traditional tissue biopsies. Liquid biopsies analyze circulating tumor cells or DNA from a blood sample, providing crucial information about the presence and progression of cancer without the need for surgery. Another area of innovation is the development of single-use, disposable biopsy devices that reduce the risk of cross-contamination and infection. These devices are particularly valuable in settings where sterility is a top priority. Additionally, advancements in robotic-assisted biopsy procedures are enhancing the precision and consistency of sample collection, reducing human error, and enabling more complex procedures to be performed with greater ease. These innovations are not only improving the efficiency of the biopsy process but are also expanding the range of conditions that can be diagnosed through biopsy.

What’s Driving the Growth in the Biopsy Devices Market?

The growth in the biopsy devices market is driven by several factors. The rising prevalence of cancer and other chronic diseases has led to an urgent need for early and accurate diagnosis, which is one of the primary drivers of market growth. Technological advancements, such as the integration of imaging technologies and the development of less invasive biopsy techniques, have significantly improved the accuracy and safety of biopsies, making them more accessible and acceptable to patients. Additionally, the trend toward personalized medicine is fueling demand for precise diagnostic tools, as treatments are increasingly tailored to the specific characteristics of an individual’s disease. Moreover, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for the adoption of advanced biopsy devices. Government initiatives and funding for cancer research and early diagnosis programs are also playing a crucial role in supporting market growth. As awareness of the importance of early detection continues to grow, the biopsy devices market is expected to experience sustained demand, driven by both technological innovations and shifts in healthcare practices globally.

Select Competitors (Total 46 Featured) -

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biopsy Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Imaging Technologies Propel Growth of Biopsy Devices Market
    • Rising Prevalence of Cancer Spurs Demand for Innovative Biopsy Solutions
    • Emerging Liquid Biopsy Techniques Expand Addressable Market Opportunity
    • Growing Preference for Minimally Invasive Procedures Strengthens Business Case for Biopsy Devices
    • Integration of AI and Machine Learning in Diagnostics Generates Demand for Enhanced Biopsy Devices
    • Aging Population and Increased Cancer Screening Programs Sustain Market Growth
    • Focus on Early Detection Solutions Propels Market Expansion
    • Innovations in Needle Design and Tissue Sampling Methods Drive Product Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopsy Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ultrasound-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for CT Scan-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Steretactics-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Imaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제